Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Camps

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 studyC Pico, M Martin, C Jara, et al.
Nature Communications|April 30, 2014
Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burdenJ-B Cazier, S R Rao, C M McLean, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 30, 2021
Future care for long-term cancer survivors: towards a new modelM Provencio, N Romero, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2005
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patientsH Cortes-Funes, C Gomez, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 12, 2018
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotypingJ Zugazagoitia, I Ramos, J M Trigo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisionsC Mayo-de-Las-Casas, N Jordana-Ariza, M Garzón-Ibañez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 studyC Pico, M Martin, C Jara, et al.
Nature Communications|April 30, 2014
Whole-genome sequencing of bladder cancers reveals somatic CDKN1A mutations and clinicopathological associations with mutation burdenJ-B Cazier, S R Rao, C M McLean, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 30, 2021
Future care for long-term cancer survivors: towards a new modelM Provencio, N Romero, J Tabernero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 27, 2005
Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patientsH Cortes-Funes, C Gomez, R Rosell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 12, 2018
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotypingJ Zugazagoitia, I Ramos, J M Trigo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisionsC Mayo-de-Las-Casas, N Jordana-Ariza, M Garzón-Ibañez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 30, 2017
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape ProjectK M Kerr, U Dafni, K Schulze, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2014
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesT Moran, J Wei, M Cobo, et al.
Pageof 11